Global Anti-Infective Vaccines Market Research Report 2020

Publisher Name :
Date: 12-Feb-2020
No. of pages: 122
Inquire Before Buying

This report focuses on Anti-Infective Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Infective Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Emergent BioDefense Operations Lansing Inc.

- Sanofi Pasteur

- Merck & Co.

- MedImmune LLC

- Novartis Vaccines

- Diagnostics Ltd.

- Intercell Biomedical

- MassBiologics

- Barr Labs, Inc.

- Organon Teknika Co.

- GlaxoSmithKline Biologicals

- CSL Ltd.

- ID Biomedical Co.

- Protein Sciences Co.

- Wyeth Pharmaceuticals, Inc.

- Berna Biotech

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Inactivated vaccines

- Conjugate vaccines

- Live/attenuated vaccines

Segment by Application

- Bacterial diseases

- Viral diseases

Global Anti-Infective Vaccines Market Research Report 2020

Table of Contents
1 Anti-Infective Vaccines Market Overview
1.1 Product Overview and Scope of Anti-Infective Vaccines
1.2 Anti-Infective Vaccines Segment by Type
1.2.1 Global Anti-Infective Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Inactivated vaccines
1.2.3 Conjugate vaccines
1.2.4 Live/attenuated vaccines
1.3 Anti-Infective Vaccines Segment by Application
1.3.1 Anti-Infective Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Bacterial diseases
1.3.3 Viral diseases
1.4 Global Anti-Infective Vaccines Market Size Estimates and Forecasts
1.4.1 Global Anti-Infective Vaccines Revenue 2015-2026
1.4.2 Global Anti-Infective Vaccines Sales 2015-2026
1.4.3 Anti-Infective Vaccines Market Size by Region: 2020 Versus 2026
2 Global Anti-Infective Vaccines Market Competition by Manufacturers
2.1 Global Anti-Infective Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Anti-Infective Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Anti-Infective Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Anti-Infective Vaccines Market Competitive Situation and Trends
2.5.1 Anti-Infective Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Anti-Infective Vaccines Players (Opinion Leaders)
3 Anti-Infective Vaccines Retrospective Market Scenario by Region
3.1 Global Anti-Infective Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Anti-Infective Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Anti-Infective Vaccines Market Facts & Figures by Country
3.3.1 North America Anti-Infective Vaccines Sales by Country
3.3.2 North America Anti-Infective Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Infective Vaccines Market Facts & Figures by Country
3.4.1 Europe Anti-Infective Vaccines Sales by Country
3.4.2 Europe Anti-Infective Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Infective Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Infective Vaccines Sales by Region
3.5.2 Asia Pacific Anti-Infective Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Infective Vaccines Market Facts & Figures by Country
3.6.1 Latin America Anti-Infective Vaccines Sales by Country
3.6.2 Latin America Anti-Infective Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Infective Vaccines Sales by Country
3.7.2 Middle East and Africa Anti-Infective Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Infective Vaccines Historic Market Analysis by Type
4.1 Global Anti-Infective Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Anti-Infective Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Anti-Infective Vaccines Price Market Share by Type (2015-2020)
4.4 Global Anti-Infective Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Anti-Infective Vaccines Historic Market Analysis by Application
5.1 Global Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Anti-Infective Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Anti-Infective Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Anti-Infective Vaccines Business
6.1 Emergent BioDefense Operations Lansing Inc.
6.1.1 Corporation Information
6.1.2 Emergent BioDefense Operations Lansing Inc. Description, Business Overview and Total Revenue
6.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Emergent BioDefense Operations Lansing Inc. Products Offered
6.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Anti-Infective Vaccines Production Sites and Area Served
6.2.2 Sanofi Pasteur Description, Business Overview and Total Revenue
6.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi Pasteur Products Offered
6.2.5 Sanofi Pasteur Recent Development
6.3 Merck & Co.
6.3.1 Merck & Co. Anti-Infective Vaccines Production Sites and Area Served
6.3.2 Merck & Co. Description, Business Overview and Total Revenue
6.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck & Co. Products Offered
6.3.5 Merck & Co. Recent Development
6.4 MedImmune LLC
6.4.1 MedImmune LLC Anti-Infective Vaccines Production Sites and Area Served
6.4.2 MedImmune LLC Description, Business Overview and Total Revenue
6.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 MedImmune LLC Products Offered
6.4.5 MedImmune LLC Recent Development
6.5 Novartis Vaccines
6.5.1 Novartis Vaccines Anti-Infective Vaccines Production Sites and Area Served
6.5.2 Novartis Vaccines Description, Business Overview and Total Revenue
6.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Novartis Vaccines Products Offered
6.5.5 Novartis Vaccines Recent Development
6.6 Diagnostics Ltd.
6.6.1 Diagnostics Ltd. Anti-Infective Vaccines Production Sites and Area Served
6.6.2 Diagnostics Ltd. Description, Business Overview and Total Revenue
6.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Diagnostics Ltd. Products Offered
6.6.5 Diagnostics Ltd. Recent Development
6.7 Intercell Biomedical
6.6.1 Intercell Biomedical Anti-Infective Vaccines Production Sites and Area Served
6.6.2 Intercell Biomedical Description, Business Overview and Total Revenue
6.6.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Intercell Biomedical Products Offered
6.7.5 Intercell Biomedical Recent Development
6.8 MassBiologics
6.8.1 MassBiologics Anti-Infective Vaccines Production Sites and Area Served
6.8.2 MassBiologics Description, Business Overview and Total Revenue
6.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 MassBiologics Products Offered
6.8.5 MassBiologics Recent Development
6.9 Barr Labs, Inc.
6.9.1 Barr Labs, Inc. Anti-Infective Vaccines Production Sites and Area Served
6.9.2 Barr Labs, Inc. Description, Business Overview and Total Revenue
6.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Barr Labs, Inc. Products Offered
6.9.5 Barr Labs, Inc. Recent Development
6.10 Organon Teknika Co.
6.10.1 Organon Teknika Co. Anti-Infective Vaccines Production Sites and Area Served
6.10.2 Organon Teknika Co. Description, Business Overview and Total Revenue
6.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Organon Teknika Co. Products Offered
6.10.5 Organon Teknika Co. Recent Development
6.11 GlaxoSmithKline Biologicals
6.11.1 GlaxoSmithKline Biologicals Anti-Infective Vaccines Production Sites and Area Served
6.11.2 GlaxoSmithKline Biologicals Anti-Infective Vaccines Description, Business Overview and Total Revenue
6.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 GlaxoSmithKline Biologicals Products Offered
6.11.5 GlaxoSmithKline Biologicals Recent Development
6.12 CSL Ltd.
6.12.1 CSL Ltd. Anti-Infective Vaccines Production Sites and Area Served
6.12.2 CSL Ltd. Anti-Infective Vaccines Description, Business Overview and Total Revenue
6.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 CSL Ltd. Products Offered
6.12.5 CSL Ltd. Recent Development
6.13 ID Biomedical Co.
6.13.1 ID Biomedical Co. Anti-Infective Vaccines Production Sites and Area Served
6.13.2 ID Biomedical Co. Anti-Infective Vaccines Description, Business Overview and Total Revenue
6.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 ID Biomedical Co. Products Offered
6.13.5 ID Biomedical Co. Recent Development
6.14 Protein Sciences Co.
6.14.1 Protein Sciences Co. Anti-Infective Vaccines Production Sites and Area Served
6.14.2 Protein Sciences Co. Anti-Infective Vaccines Description, Business Overview and Total Revenue
6.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Protein Sciences Co. Products Offered
6.14.5 Protein Sciences Co. Recent Development
6.15 Wyeth Pharmaceuticals, Inc.
6.15.1 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Production Sites and Area Served
6.15.2 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Description, Business Overview and Total Revenue
6.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Wyeth Pharmaceuticals, Inc. Products Offered
6.15.5 Wyeth Pharmaceuticals, Inc. Recent Development
6.16 Berna Biotech
6.16.1 Berna Biotech Anti-Infective Vaccines Production Sites and Area Served
6.16.2 Berna Biotech Anti-Infective Vaccines Description, Business Overview and Total Revenue
6.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Berna Biotech Products Offered
6.16.5 Berna Biotech Recent Development
7 Anti-Infective Vaccines Manufacturing Cost Analysis
7.1 Anti-Infective Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Infective Vaccines
7.4 Anti-Infective Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Infective Vaccines Distributors List
8.3 Anti-Infective Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Anti-Infective Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Infective Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Anti-Infective Vaccines by Type (2021-2026)
10.2 Anti-Infective Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Infective Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Anti-Infective Vaccines by Application (2021-2026)
10.3 Anti-Infective Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Infective Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Anti-Infective Vaccines by Region (2021-2026)
10.4 North America Anti-Infective Vaccines Estimates and Projections (2021-2026)
10.5 Europe Anti-Infective Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Anti-Infective Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Anti-Infective Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Anti-Infective Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Infective Vaccines Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Anti-Infective Vaccines Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Anti-Infective Vaccines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Anti-Infective Vaccines Manufacturers Covered in This Study
Table 5. Global Anti-Infective Vaccines Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Anti-Infective Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global Anti-Infective Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Anti-Infective Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Anti-Infective Vaccines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Anti-Infective Vaccines Sales Sites and Area Served
Table 11. Manufacturers Anti-Infective Vaccines Product Types
Table 12. Global Anti-Infective Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Infective Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Infective Vaccines as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Anti-Infective Vaccines Players
Table 16. Global Anti-Infective Vaccines Sales (K Units) by Region (2015-2020)
Table 17. Global Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global Anti-Infective Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 21. North America Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 25. Europe Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Anti-Infective Vaccines Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Anti-Infective Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 33. Latin America Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Anti-Infective Vaccines Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Anti-Infective Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global Anti-Infective Vaccines Sales (K Units) by Type (2015-2020)
Table 41. Global Anti-Infective Vaccines Sales Share by Type (2015-2020)
Table 42. Global Anti-Infective Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Anti-Infective Vaccines Revenue Share by Type (2015-2020)
Table 44. Global Anti-Infective Vaccines Price (USD/Unit) by Type (2015-2020)
Table 45. Global Anti-Infective Vaccines Sales (K Units) by Application (2015-2020)
Table 46. Global Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global Anti-Infective Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Corporation Information
Table 49. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 50. Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Emergent BioDefense Operations Lansing Inc. Main Product
Table 52. Emergent BioDefense Operations Lansing Inc. Recent Development
Table 53. Sanofi Pasteur Anti-Infective Vaccines Corporation Information
Table 54. Sanofi Pasteur Corporation Information
Table 55. Sanofi Pasteur Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi Pasteur Main Product
Table 57. Sanofi Pasteur Recent Development
Table 58. Merck & Co. Anti-Infective Vaccines Corporation Information
Table 59. Merck & Co. Corporation Information
Table 60. Merck & Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Merck & Co. Main Product
Table 62. Merck & Co. Recent Development
Table 63. MedImmune LLC Anti-Infective Vaccines Corporation Information
Table 64. MedImmune LLC Corporation Information
Table 65. MedImmune LLC Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. MedImmune LLC Main Product
Table 67. MedImmune LLC Recent Development
Table 68. Novartis Vaccines Anti-Infective Vaccines Corporation Information
Table 69. Novartis Vaccines Corporation Information
Table 70. Novartis Vaccines Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Novartis Vaccines Main Product
Table 72. Novartis Vaccines Recent Development
Table 73. Diagnostics Ltd. Anti-Infective Vaccines Corporation Information
Table 74. Diagnostics Ltd. Corporation Information
Table 75. Diagnostics Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Diagnostics Ltd. Main Product
Table 77. Diagnostics Ltd. Recent Development
Table 78. Intercell Biomedical Anti-Infective Vaccines Corporation Information
Table 79. Intercell Biomedical Corporation Information
Table 80. Intercell Biomedical Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Intercell Biomedical Main Product
Table 82. Intercell Biomedical Recent Development
Table 83. MassBiologics Anti-Infective Vaccines Corporation Information
Table 84. MassBiologics Corporation Information
Table 85. MassBiologics Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. MassBiologics Main Product
Table 87. MassBiologics Recent Development
Table 88. Barr Labs, Inc. Anti-Infective Vaccines Corporation Information
Table 89. Barr Labs, Inc. Corporation Information
Table 90. Barr Labs, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Barr Labs, Inc. Main Product
Table 92. Barr Labs, Inc. Recent Development
Table 93. Organon Teknika Co. Anti-Infective Vaccines Corporation Information
Table 94. Organon Teknika Co. Corporation Information
Table 95. Organon Teknika Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Organon Teknika Co. Main Product
Table 97. Organon Teknika Co. Recent Development
Table 98. GlaxoSmithKline Biologicals Anti-Infective Vaccines Corporation Information
Table 99. GlaxoSmithKline Biologicals Corporation Information
Table 100. GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. GlaxoSmithKline Biologicals Main Product
Table 102. GlaxoSmithKline Biologicals Recent Development
Table 103. CSL Ltd. Anti-Infective Vaccines Corporation Information
Table 104. CSL Ltd. Corporation Information
Table 105. CSL Ltd. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. CSL Ltd. Main Product
Table 107. CSL Ltd. Recent Development
Table 108. ID Biomedical Co. Anti-Infective Vaccines Corporation Information
Table 109. ID Biomedical Co. Corporation Information
Table 110. ID Biomedical Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. ID Biomedical Co. Main Product
Table 112. ID Biomedical Co. Recent Development
Table 113. Protein Sciences Co. Anti-Infective Vaccines Corporation Information
Table 114. Protein Sciences Co. Corporation Information
Table 115. Protein Sciences Co. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Protein Sciences Co. Main Product
Table 117. Protein Sciences Co. Recent Development
Table 118. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Corporation Information
Table 119. Wyeth Pharmaceuticals, Inc. Corporation Information
Table 120. Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Wyeth Pharmaceuticals, Inc. Main Product
Table 122. Wyeth Pharmaceuticals, Inc. Recent Development
Table 123. Berna Biotech Anti-Infective Vaccines Corporation Information
Table 124. Berna Biotech Corporation Information
Table 125. Berna Biotech Anti-Infective Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Berna Biotech Main Product
Table 127. Berna Biotech Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Anti-Infective Vaccines Distributors List
Table 131. Anti-Infective Vaccines Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Anti-Infective Vaccines Sales (K Units) Forecast by Type (2021-2026)
Table 136. Global Anti-Infective Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Anti-Infective Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Anti-Infective Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Anti-Infective Vaccines Sales (K Units) Forecast by Application (2021-2026)
Table 140. Global Anti-Infective Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Anti-Infective Vaccines Sales (K Units) Forecast by Region (2021-2026)
Table 142. Global Anti-Infective Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Anti-Infective Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Anti-Infective Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Anti-Infective Vaccines
Figure 2. Global Anti-Infective Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. Inactivated vaccines Product Picture
Figure 4. Conjugate vaccines Product Picture
Figure 5. Live/attenuated vaccines Product Picture
Figure 6. Global Anti-Infective Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 7. Bacterial diseases
Figure 8. Viral diseases
Figure 9. Global Anti-Infective Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global Anti-Infective Vaccines Sales Capacity (K Units) (2015-2026)
Figure 11. Global Anti-Infective Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Anti-Infective Vaccines Sales Share by Manufacturers in 2020
Figure 13. Global Anti-Infective Vaccines Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Anti-Infective Vaccines Revenue in 2019
Figure 15. Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Anti-Infective Vaccines Sales Market Share by Region (2015-2020)
Figure 17. Global Anti-Infective Vaccines Sales Market Share by Region in 2019
Figure 18. Global Anti-Infective Vaccines Revenue Market Share by Region (2015-2020)
Figure 19. Global Anti-Infective Vaccines Revenue Market Share by Region in 2019
Figure 20. North America Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 21. North America Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 22. U.S. Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 27. Europe Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 28. Germany Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Anti-Infective Vaccines Sales Market Share by Region in 2019
Figure 39. Asia Pacific Anti-Infective Vaccines Revenue Market Share by Region in 2019
Figure 40. China Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 63. Latin America Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 64. Mexico Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Anti-Infective Vaccines Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Anti-Infective Vaccines Revenue Market Share by Country in 2019
Figure 72. Turkey Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Anti-Infective Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Anti-Infective Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Anti-Infective Vaccines by Type (2015-2020)
Figure 79. Sales Market Share of Anti-Infective Vaccines by Type in 2019
Figure 80. Revenue Share of Anti-Infective Vaccines by Type (2015-2020)
Figure 81. Revenue Market Share of Anti-Infective Vaccines by Type in 2019
Figure 82. Global Anti-Infective Vaccines Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Anti-Infective Vaccines Sales Market Share by Application (2015-2020)
Figure 84. Global Anti-Infective Vaccines Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Anti-Infective Vaccines by Application (2015-2020)
Figure 86. Global Revenue Share of Anti-Infective Vaccines by Application in 2020
Figure 87. Emergent BioDefense Operations Lansing Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. MedImmune LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Novartis Vaccines Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Diagnostics Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Intercell Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. MassBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Barr Labs, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Organon Teknika Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. GlaxoSmithKline Biologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. CSL Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. ID Biomedical Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Protein Sciences Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Wyeth Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Berna Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Price Trend of Key Raw Materials
Figure 104. Manufacturing Cost Structure of Anti-Infective Vaccines
Figure 105. Manufacturing Process Analysis of Anti-Infective Vaccines
Figure 106. Anti-Infective Vaccines Industrial Chain Analysis
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Porter's Five Forces Analysis
Figure 110. North America Anti-Infective Vaccines Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. North America Anti-Infective Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Europ
  • Global Human Fibrinogen Market Growth 2020-2025
    Published: 21-Feb-2020        Price: US 3660 Onwards        Pages: 138
    According to this study, over the next five years the Human Fibrinogen market will register a 25.9% CAGR in terms of revenue, the global market size will reach $ 1855.3 million by 2025, from $ 737.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Fibrinogen business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Human Fibrinogen market by type......
  • Global Perphenazine Market Growth 2020-2025
    Published: 21-Feb-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Perphenazine market will register a 0.6% CAGR in terms of revenue, the global market size will reach $ 96.9 million by 2025, from $ 95 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Perphenazine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Perphenazine market by type, application, key......
  • Global Sex Hormones Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 21-Feb-2020        Price: US 3480 Onwards        Pages: 108
    Market Overview The global Sex Hormones market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sex Hormones market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of ......
  • Global Steroids Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 21-Feb-2020        Price: US 3480 Onwards        Pages: 106
    Market Overview The global Steroids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Steroids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic......
  • Global Pharmaceutical Sofegel Capsules Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 21-Feb-2020        Price: US 3480 Onwards        Pages: 104
    Market Overview The global Pharmaceutical Sofegel Capsules market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pharmaceutical Sofegel Capsules market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive......
  • Global Human Coagulation Factor ? Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 21-Feb-2020        Price: US 3480 Onwards        Pages: 103
    Market Overview The global Human Coagulation Factor ? market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Coagulation Factor ? market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape......
  • Global Quinidine Sulfate Market Research Report 2020
    Published: 20-Feb-2020        Price: US 2900 Onwards        Pages: 93
    This report focuses on Quinidine Sulfate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Quinidine Sulfate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in ......
  • Global Progesterone Market Research Report 2020
    Published: 20-Feb-2020        Price: US 2900 Onwards        Pages: 90
    This report focuses on Progesterone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Progesterone market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this repor......
  • Global Pregabalin Market Research Report 2020
    Published: 20-Feb-2020        Price: US 2900 Onwards        Pages: 130
    This report focuses on Pregabalin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pregabalin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs